| $385M | ||
| $350M | ||
| $215M | ||
| $94M | ||
| $82M | ||
| $62M |
Buys | $124,750 | 3 | 75 |
Sells | $732 | 1 | 25 |
| CARUSO JAMES V | Chief Executive Officer | 1 | $49,900 | 0 | $0 | $49,900 |
| Longcor Jarrod | Chief Operating Officer | 1 | $49,900 | 0 | $0 | $49,900 |
| Kolean Chad J | Chief Financial Officer | 1 | $24,950 | 0 | $0 | $24,950 |
| NEIS JOHN | director | 0 | $0 | 1 | $732 | $-732 |
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC programs with Avicenna Oncology GMBH to develop CLR 2000 Series; Orano Med to develop CLR 12120 Series; IntoCell Inc; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.
Over the last 12 months, insiders at Cellectar Biosciences, Inc. have bought $124,750 and sold $732 worth of Cellectar Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Cellectar Biosciences, Inc. have bought $62,684 and sold $732 worth of stock each year.
Highest buying activity among insiders over the last 12 months: CARUSO JAMES V (Chief Executive Officer) — $49,900. Longcor Jarrod (Chief Operating Officer) — $49,900. Kolean Chad J (Chief Financial Officer) — $24,950.
The last purchase of 10,000 shares for transaction amount of $49,900 was made by Longcor Jarrod (Chief Operating Officer) on 2025‑07‑02.
| 2025-12-12 | Sale | NEIS JOHN | director | 198 0.0063% | $3.70 | $732 | -11.05% | |
| 2025-07-02 | Longcor Jarrod | Chief Operating Officer | 10,000 0.0229% | $4.99 | $49,900 | -9.30% | ||
| 2025-07-02 | CARUSO JAMES V | Chief Executive Officer | 10,000 0.0229% | $4.99 | $49,900 | -9.30% | ||
| 2025-07-02 | Kolean Chad J | Chief Financial Officer | 5,000 0.0114% | $4.99 | $24,950 | -9.30% | ||
| 2025-01-10 | Longcor Jarrod | Chief Operating Officer | 30,000 0.0723% | $0.28 | $8,400 | -34.95% | ||
| 2021-09-14 | Swirsky Douglas J | director | 25,000 0.0418% | $1.04 | $26,000 | -43.80% | ||
| 2021-09-03 | DRISCOLL FREDERICK W | director | 19,417 0.0328% | $1.04 | $20,244 | -42.72% | ||
| 2021-03-04 | CARUSO JAMES V | President and CEO | 5,100 0.0103% | $1.70 | $8,659 | -43.68% | ||
| 2020-12-28 | Longcor Jarrod | Chief Business Officer | 29,630 0.0975% | $1.35 | $40,001 | -41.79% | ||
| 2020-12-28 | CARUSO JAMES V | President and CEO | 37,037 0.1219% | $1.35 | $50,000 | -41.79% | ||
| 2020-12-28 | Elefant Dov | Chief Financial Officer | 7,407 0.0244% | $1.35 | $9,999 | -41.79% | ||
| 2020-06-05 | Longcor Jarrod | Chief Business Officer | 65,218 0.4749% | $1.15 | $74,675 | +26.32% | ||
| 2020-06-05 | CARUSO JAMES V | President and CEO | 21,740 0.1583% | $1.15 | $24,892 | +26.32% | ||
| 2020-06-05 | Elefant Dov | Chief Financial Officer | 4,348 0.0317% | $1.15 | $4,978 | +26.32% | ||
| 2020-06-04 | HILL STEPHEN A | director | 18,000 0.1236% | $1.08 | $19,438 | +25.88% | ||
| 2019-02-28 | Longcor Jarrod | Chief Business Officer | 100 0.0021% | $2.00 | $200 | +6.90% | ||
| 2018-11-30 | CARUSO JAMES V | President and CEO | 1,000 0.0345% | $2.28 | $2,282 | -4.93% | ||
| 2018-11-29 | Sale | HILL STEPHEN A | director | 992 0.0329% | $2.21 | $2,192 | -5.78% | |
| 2018-08-16 | Longcor Jarrod | Chief Business Officer | 500 0.0149% | $2.71 | $1,355 | -22.38% | ||
| 2018-03-13 | Sale | Longcor Jarrod | Chief Business Officer | 13,000 0.0783% | $1.18 | $15,397 | -76.50% |
| Longcor Jarrod | Chief Operating Officer | 12768 0.4% | $38,814.72 | 6 | 1 | <0.0001% |
| CARUSO JAMES V | Chief Executive Officer | 11638 0.3646% | $35,379.52 | 10 | 1 | <0.0001% |
| Kolean Chad J | Chief Financial Officer | 6418 0.2011% | $19,510.72 | 1 | 0 | |
| NEIS JOHN | director | 10 0.0003% | $30.40 | 3 | 2 | |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10 percent owner | 1142368 35.788% | $3.47M | 4 | 0 | |
| Hertzberg Richard | 280000 8.7718% | $851,200.00 | 12 | 1 | ||
| BERNS PAUL L | director | 117371 3.677% | $356,807.84 | 1 | 0 | |
| Swirsky Douglas J | director | 25000 0.7832% | $76,000.00 | 1 | 0 | |
| DRISCOLL FREDERICK W | director | 19417 0.6083% | $59,027.68 | 1 | 0 | |
| HILL STEPHEN A | director | 18000 0.5639% | $54,720.00 | 3 | 1 | +25.88% |
| Pedder Simon | President and CEO | 13300 0.4167% | $40,432.00 | 1 | 0 | |
| Elefant Dov | Chief Financial Officer | 11755 0.3683% | $35,735.20 | 2 | 0 | <0.0001% |
| AWM Investment Company, Inc. | 10 percent owner | 0 0% | $0 | 0 | 28 |
$8,253,997 | 122 | -53.40% | $11.18M | |
$1,848,072 | 66 | -14.67% | $9.23M | |
$17,168,388 | 54 | -43.55% | $11.83M | |
$226,127 | 22 | -27.62% | $9.33M | |
$37,197,670 | 19 | -48.42% | $11.08M | |
$6,733,543 | 17 | -19.02% | $8.93M | |
$49,590 | 16 | -37.31% | $9.9M | |
$25,487,383 | 15 | -4.37% | $13.32M | |
$1,246,170 | 12 | 65.67% | $10.94M | |
$4,146,041 | 11 | -40.86% | $9.42M | |
$188,726 | 11 | -28.87% | $8.24M | |
$20,759,738 | 11 | -44.68% | $9.33M | |
$11,777,042 | 10 | -11.94% | $8.43M | |
Cellectar Biosciences, Inc. (CLRB) | $241,042 | 9 | -11.02% | $9.7M |
$2,060,158 | 5 | -21.35% | $9.94M | |
$1,184,658 | 4 | -22.17% | $9.06M | |
$14,530 | 3 | 62.23% | $11.4M | |
$9,828 | 3 | -32.17% | $12.96M | |
$28,395 | 3 | 3.48% | $9.22M |
| Increased Positions | 15 | +88.24% | 225,440 | +205.85% |
| Decreased Positions | 6 | -35.29% | 13,099 | -11.96% |
| New Positions | 7 | New | 188,406 | New |
| Sold Out Positions | 4 | Sold Out | 12,950 | Sold Out |
| Total Postitions | 26 | +52.94% | 321,856 | +193.89% |
| Bleichroeder Lp | $347.00 | 2.5% | 100,000 | +100,000 | New | 2025-09-30 |
| Vanguard Group Inc | $226.00 | 1.63% | 65,171 | +8,830 | +15.67% | 2025-09-30 |
| Renaissance Technologies Llc | $86.00 | 0.62% | 24,900 | +24,900 | New | 2025-09-30 |
| Geode Capital Management, Llc | $86.00 | 0.62% | 24,892 | +10,453 | +72.39% | 2025-09-30 |
| Drw Securities, Llc | $73.00 | 0.53% | 21,101 | +21,101 | New | 2025-09-30 |
| Citadel Advisors Llc | $64.00 | 0.46% | 18,526 | +18,526 | New | 2025-09-30 |
| Dimensional Fund Advisors Lp | $45.00 | 0.33% | 13,033 | +13,033 | New | 2025-09-30 |
| Sequoia Financial Advisors, Llc | $37.00 | 0.27% | 10,783 | +10,783 | New | 2025-09-30 |
| Riverview Capital Advisers, Llc | $36.00 | 0.26% | 10,384 | -116 | -1.1% | 2025-09-30 |
| Blackrock, Inc. | $16.00 | 0.12% | 4,745 | +3 | +0.06% | 2025-09-30 |